ConvaTec completes $900M private placement; Nipro Diagnostics makes an acquisition;

@FierceMedDev: Trending on FierceMedicalDevices.com: Medtronic bags telehealth biz for $200M. More | Follow @FierceMedDev

@DamianFierce: GenMark wants to turn the page on June's plunge with a $60M stock sale. Story | Follow @DamianFierce

@MichaelGFierce: Receptor-targeted antifolate drugs yield fewer side effects. More from FierceDrugDelivery | Follow @MichaelGFierce

> ConvaTec, a maker of medical devices and equipment, has completed a $900 million private placement designed to repay preferred equity certificates. Item

> Covidien ($COV) is rolling out a new radiofrequency ablation catheter. Item

> California's BioVentrix notched the first use of its Revivent myocardial anchoring system through a less invasive ventricular enhancement procedure. News

> Oasis Diagnostics scored $1.3 million in funding from the National Institutes of Health (NIH) to develop its real-time stress test that detects levels of the hormone cortisol in saliva. More

> Diabetes devicemaker Nipro Diagnostics has bought manufacturer P.J. Noyes for an undisclosed sum. Release

> Quantel Medical gained FDA clearance for its SLT glaucoma laser, following the expiration of a Massachusetts General Hospital patent that restricted it and other rivals from marketing similar devices in the U.S. Item

Biotech News

@FierceBiotech: ICYMI: Biotechs crowd list of top growth leaders as Big Pharmas shrink staffs. Feature | Follow @FierceBiotech

@JohnCFierce: If the OS results for necitumumab were more than very, very slim, I'll be surprised. | Follow @JohnCFierce

@RyanMFierce: Why not. Langer's Bind files $80M IPO as new biotech offerings go gangbusters. Story | Follow @RyanMFierce

> GlaxoSmithKline JV wins FDA OK on HIV blockbuster dolutegravir. Report

> Bristol-Myers buries another depression drug after PhII flops. Story

> Biotech accelerator BioMotiv gets a $20M commitment from new investor. Article

Pharma News

@FiercePharma: Twist for Perrigo's Elan buy, per Leerink Swann: Perrigo must maintain Irish headcount to keep key tax breaks. So cost-cutting ability limited. | Follow @FiercePharma

@CarlyHFierce: Regeneron puts $70M in plant expansion amid growing Eylea demand. More from FiercePharmaManufacturing | Follow @CarlyHFierce

> What do pharma reps need to get face time with doctors? Report

> Lawmakers demand Purdue Pharma's list of suspect OxyContin prescribers. News

> Mylan assures India it won't dismiss domestic market with Agila buy. Item

Pharma Manufacturing News

@EricPFierce: India's Aurobindo Pharma expanding its sterile injectables capacity at newest facility. More from FiercePharma.com | Follow @EricPFierce

> Russia's Pharmstandard to buy Singapore API maker. News

> Compounder recalls drugs that may have caused infections. Item

> Mylan geared up for big expansion in India. More

> Manufacturing issues trip up Novo on new therapy. Article

> India's Aurobindo buys, boosts sterile capacity. Story

Biotech Research News

@EmilyMFierce: U.K. nonprofits offering funding for novel Parkinson's targets. More from FierceBiotechResearch.com | Follow @EmilyMFierce

> NIH to open genomic data of HeLa cells to researchers. Story

> Newly discovered proteins could play role in destroying cancer cells. Article

> Stem cell combo therapy extends survival of mice with brain tumors. More

> University of Maryland, Baltimore partners with 5 biotech companies. Item

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.